| Location |
Stanford, California, USA |
| Type |
Academic Medical Center / Research Institute |
| Founded |
1970s (Neuroscience Institute) |
| Affiliation |
Stanford University School of Medicine |
| Website |
med.stanford.edu/neurology |
| Focus Areas |
Alzheimer's Disease, Parkinson's Disease, DLB, ALS, FTD |
Stanford Neuroscience Health Care represents the comprehensive neuroscience enterprise at Stanford University School of Medicine, encompassing the Department of Neurology, the Stanford Neuroscience Institute, and multiple specialized centers focused on neurodegenerative diseases. Located in Stanford, California, Stanford has become one of the world's leading centers for neuroscience research and clinical care.
The institution's research spans the full spectrum of neurodegenerative diseases, with particular strength in Alzheimer's disease, Parkinson's disease, dementia with Lewy bodies, frontotemporal dementia, and amyotrophic lateral sclerosis[@achin2019; @poston2023; @thaler2024].
¶ History and Development
Stanford University's medical enterprise has grown substantially since its founding:
- 1960s: Neurology department established
- 1970s: Stanford Neuroscience Institute formed
- 1990s: Expansion of neurodegenerative disease research
- 2000s: Development of specialized memory and movement disorder centers
- 2010s: Launch of precision medicine initiatives
- 2020s: Leadership in biomarker and therapeutic development
Stanford maintains a comprehensive AD research program:
Key Research Areas:
- Amyloid and tau biology and imaging
- Biomarker development for early detection
- Clinical trials of novel therapeutics
- APOE and genetic risk factors
- Neuroinflammation mechanisms
¶ Parkinson's Disease and Movement Disorders
The movement disorders program is internationally recognized[@poston2023]:
Research Focus:
- Alpha-synuclein biology and propagation
- Genetic forms of PD (LRRK2, GBA, SNCA)
- Deep brain stimulation optimization
- Non-motor symptoms
- Biomarker development
¶ Lewy Body Dementia Program
Stanford has developed a leading DLB research program[@thaler2024]:
Core Research Themes:
- Clinical characterization and diagnosis
- Sleep disorders and DLB
- Biomarker development
- Therapeutic approaches
Research on FTD encompasses:
¶ ALS and Motor Neuron Disease
Stanford is a major ALS research center:
- Genetic discovery and characterization
- Biomarker development
- Clinical trials
- Patient care and support
Comprehensive services for dementia patients:
- Multi-disciplinary evaluation
- State-of-the-art diagnostics
- Access to clinical trials
- Caregiver support programs
Expert care for Parkinson's and related disorders:
- Medical management
- Deep brain stimulation programming
- Physical therapy integration
- Clinical research access
Multidisciplinary care for ALS patients:
- Neurology and pulmonology
- Nutrition and respiratory support
- Clinical trials access
- Patient and family support
- Dr. Michael Greicius: Alzheimer's disease neuroimaging and biomarkers
- Dr. Kathleen Poston: Parkinson's disease and movement disorders[@poston2023]
- Dr. Adam Thaler: Dementia with Lewy bodies and sleep disorders[@thaler2024]
- Dr. Jeremy Schmahmann: Ataxia and cerebellar disorders
Stanford offers extensive training:
- Neurology residency
- Movement disorders fellowship
- Cognitive neurology fellowship
- Research fellowships in all neurodegenerative areas
- Graduate student programs
¶ Collaboration and Partnerships
Stanford collaborates with:
- Stanford University
- UCSF
- National Institute on Aging (NIA)
- Michael J. Fox Foundation
- Alzheimer's Association
- Pharmaceutical industry partners
- Precision medicine: Personalized approaches to neurodegeneration
- Biomarkers: Early detection and disease monitoring
- Therapeutics: Drug discovery and clinical trials
- Technology: AI and digital health integration
- Single-cell genomics
- Organoid and model systems
- Gene therapy approaches
- Immunotherapy development
- Achin K, et al. Stanford Neuroscience Health Care and Alzheimer's Disease Research. Alzheimer's & Dementia (2019)
- Poston KL, et al. Parkinson's Disease Research at Stanford: Alpha-Synuclein and Movement Disorders. Movement Disorders (2023)
- Thaler A, et al. Dementia with Lewy Bodies at Stanford Neuroscience Health Care. Neurology (2024)